These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 17845980)

  • 1. [Gemcitabine and pemetrexed in genito-urinary tumors treatment].
    Fléchon A
    Bull Cancer; 2007; 94 Spec No Actualites():S116-21. PubMed ID: 17845980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pemetrexed in transitional cell carcinoma of the urothelium.
    von der Maase H
    Oncology (Williston Park); 2004 Nov; 18(13 Suppl 8):48-50. PubMed ID: 15655937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The present and future of combination chemotherapy in bladder cancer.
    Culine S
    Semin Oncol; 2002 Jun; 29(3 Suppl 9):32-9. PubMed ID: 12094336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gemcitabine and Pemetrexed disodium in treating breast cancer.
    Adjei AA
    Oncology (Williston Park); 2001 Feb; 15(2 Suppl 3):34-7. PubMed ID: 11252887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gemcitabine and urogenital tumors].
    Culine S
    Bull Cancer; 2002 Aug; 89 Spec No():S102-6. PubMed ID: 12449039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neoadjuvant chemotherapy for urothelial tumors].
    Culine S
    Rev Prat; 2014 Dec; 64(10):1399. PubMed ID: 25665321
    [No Abstract]   [Full Text] [Related]  

  • 7. Introduction: the emerging roles of gemcitabine and MTA in the treatment of non-small cell lung cancer.
    Johnson D; Tonato M
    Semin Oncol; 1999 Feb; 26(1 Suppl 4):1-2. PubMed ID: 10201514
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of pemetrexed combined with gemcitabine for non-small-cell lung cancer.
    Ngeow J; Toh CK
    Curr Drug Targets; 2010 Jan; 11(1):61-6. PubMed ID: 19839926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemotherapy for urothelial infiltrating tumors].
    Culine S
    Cancer Radiother; 1998; 2(5):515-20. PubMed ID: 9868395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of gemcitabine and paclitaxel is a favorable option for patients with advanced or metastatic urothelial carcinoma previously treated with cisplatin-based chemotherapy.
    Ikeda M; Matsumoto K; Tabata K; Minamida S; Fujita T; Satoh T; Iwamura M; Baba S
    Jpn J Clin Oncol; 2011 Oct; 41(10):1214-20. PubMed ID: 21903707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gemcitabine and cisplatin therapy in advanced or metastatic urothelial cancer: comparison of side effect with MVAC (methotrexate, vinblastine, doxorubicin, and cisplatin)].
    Ochi T; Ozawa A; Tanji N; Yanagihara Y; Yanagaki T; Miyauchi Y; Ikeda T; Shimamoto K; Toshino A; Sugawara T; Hamada H; Yokoyama M
    Nihon Hinyokika Gakkai Zasshi; 2006 Sep; 97(6):777-81. PubMed ID: 17025209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pemetrexed plus platinum or gemcitabine plus platinum for advanced non-small cell lung cancer: final survival analysis from a multicentre randomized phase II trial in the East Asia region and a meta-analysis.
    Zhang X; Lu J; Xu J; Li H; Wang J; Qin Y; Ma P; Wei L; He J
    Respirology; 2013 Jan; 18(1):131-9. PubMed ID: 22882698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pemetrexed in pancreatic cancer.
    Kindler HL
    Semin Oncol; 2002 Dec; 29(6 Suppl 18):49-53. PubMed ID: 12571811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gemcitabine/cisplatin vs. MVAC. 5 year survival outcome of the phase III study of chemotherapy of advanced urothelial carcinoma in Germany].
    Lehmann J; Retz M; Steiner G; Albers P; Jaeger E; Knuth A; Lippert C; Koser M; Stockamp K; Otto C; Melchior H; Fassmann C; Potratz C; Loch T; Derigs HG; Becker T; Kälble T; Piechota HJ; Hertle L; Weinknecht S; Weissbach L; Al-Mwalad M; Hamza A; Henss H; Brkovic D; Pomer S; Roloff J; Walz P; Muschter R; Tunn U; Winter E; Bub P; Kaldenbach U; Roth S; Brauers A; Jakse G; Richter AE; Wirth M; Hartlapp J; Van Ahlen H; Stöckle M
    Urologe A; 2003 Aug; 42(8):1074-86. PubMed ID: 14513232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale for the use of gemcitabine in breast cancer (Review).
    Silvestris N; D'Aprile M; Andreola G; Locopo N; Marini L; Crucitta E; De Lena M; Lorusso V
    Int J Oncol; 2004 Feb; 24(2):389-98. PubMed ID: 14719116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What news in urological cancer.
    Lorusso V
    Tunis Med; 2005 Dec; 83 Suppl 12():75-6. PubMed ID: 16430074
    [No Abstract]   [Full Text] [Related]  

  • 17. Cisplatin and gemcitabine in malignant mesothelioma.
    Nowak AK; Byrne MJ
    Ann Oncol; 2005 Oct; 16(10):1711. PubMed ID: 16000339
    [No Abstract]   [Full Text] [Related]  

  • 18. [Efficacy and toxicity of pemetrexed or gemcitabine combined with cisplatin in the treatment of patients with advanced non-small cell lung cancer].
    Hu X; Jiao S; Zhang S; Wang Z; Wang M; Huang C; Zheng R; Li K; Wang J; Wang Y; Ouyang X; Lv W; Cheng G; Hu C; Luo R; Sun Y
    Zhongguo Fei Ai Za Zhi; 2012 Oct; 15(10):569-75. PubMed ID: 23075680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gemcitabine and paclitaxel chemotherapy as a second-line treatment for advanced or metastatic urothelial carcinoma.
    Matsumoto K; Irie A; Satoh T; Okazaki M; Iwamura M; Baba S
    Int J Urol; 2007 Nov; 14(11):1000-4; discussion 1004. PubMed ID: 17956525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incorporation of pemetrexed (Alimta) into the treatment of non-small cell lung cancer (thoracic tumors).
    Bunn PA
    Semin Oncol; 2002 Jun; 29(3 Suppl 9):17-22. PubMed ID: 12094334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.